Table 1 Baseline information of comparative studies enrolled in the meta-analysis
References | Country | Year | Design | Patients | Imaging examinations | Age | No. of patients | |
|---|---|---|---|---|---|---|---|---|
Qin et al. | China | 2022 | Comparative study | Histopathologically proven diagnosis of gastric cancer | 68Ga-FAPI-04 MRI | 18F-FDG CT | Median age 56 (range 29–70) | 20 (9 m;11f) |
Gündoğan et al. | Turkey | 2021 | Comparative study | Histopathologically proven diagnosis of gastric cancer | 68Ga-FAPI-04 CT | 18F-FDG CT | Median age 61 (range 40–81) | 21 (12 m;9f) |
Jiang et al. | China | 2021 | Comparative study | Histopathologically proven diagnosis of gastric cancer | 68Ga-FAPI-04 MRI/CT | 18F-FDG MRI/CT | Median age 67.5 (range 25–86) | 38 (29 m,9f) |
Lin et al. | China | 2022 | Comparative study | Histopathologically proven diagnosis of gastric cancer | 68Ga-FAPI-04 CT | 18F-FDG CT | Median age 63.8 ± 14.9 (range 28–85) | 56 (40 m;16f) |
Kuten et al. | Israel | 2021 | Comparative study | Histopathologically proven diagnosis of gastric cancer | 68Ga-FAPI-04 CT | 18F-FDG CT | Median age 70 (range 35–87) | 13 (6 M,7F) |